';
Physical Disabilities & Aging

RCPA is delighted to share our 2023 Year in Review! We’re confident that this review will provide you with valuable insights, and inspire you as we highlight some of our significant achievements. This past year, we have embarked on groundbreaking initiatives and celebrated remarkable successes, all thanks to our collective efforts. As we step into 2024, we remain optimistic about reaching new heights together, and hope this review fuels your enthusiasm for what we can all accomplish in the coming year.

The Office of Developmental Programs (ODP) has shared this important announcement from the U.S. Food and Drug Administration (FDA) about a recall of two cough medicine products by Robitussin. The products are Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. Please see the specific Lot Numbers below that are involved in the recall.  If you have one of these products with the matching Lot Number, stop use immediately and contact your health care provider.


Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination

Summary
Company Announcement Date: January 24, 2024
FDA Publish Date: January 24, 2024
Product Type: Drugs
Reason for Announcement: Microbial Contamination
Company Name: Haleon
Brand Name: Robitussin
Product Description: Cough syrups

Haleon is voluntarily recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult to the consumer level. The product is being recalled due to microbial contamination.

In immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events, such as fungemia or disseminated fungal infection. In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out. To date, Haleon has not received any reports of adverse events related to this recall.

Robitussin Honey CF Max Day and Nighttime are cough syrups indicated for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies. This recall covers only the following lots:

Product Lot Number Expiry Date
ROBITUSSIN HONEY CF MAX
DAY ADULT 4OZ
T10810 31OCT2025
ROBITUSSIN HONEY CF MAX
DAY ADULT 8OZ
T08730
T08731
T08732
T08733
T10808
31MAY2025
31MAY2025
31MAY2025
31MAY2025
30SEP2025
ROBITUSSIN HONEY CF MAX
NT ADULT 8OZ
T08740 T08742 30JUN2026
30JUN2026

Haleon is notifying its distributors and customers directly and has provided them with instructions for the return of all recalled products. Consumers that have purchased the product listed should stop consumption immediately. Please call our Consumer Relations team at +1-800-245-1040 (Monday through Friday 8:00 am – 6:00 pm Eastern Time) or reach out via email.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

  • Complete and submit the report online
  • Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Information was issued on January 11, 2024, regarding a second virtual transportation summit that has been planned for February 7, 2024.

Due to the original webinar not being accessible to everyone, the decision was made to change the format of the summit to a Teams virtual meeting. The meeting is open to the public, transportation providers, and anyone interested in transportation issues in the Community HealthChoices (CHC) program.

The purpose of the meeting is to have a full and robust discussion about transportation concerns and needs. There will be staff from various programs on the call, including the CHC Managed Care Organizations (MCO) and transportation brokers, MATP, and PennDOT. They will be on the call to listen to the issues and answer questions as they can.

This is a follow-up to the meeting held on December 11, 2023. This meeting will not have any formal presentations but will allow for participants, providers, and attendees to discuss their transportation issues, difficulties, or positive experiences. Participants can also ask questions during the webinar by either raising their hand and waiting until they are unmuted or by asking their question in the chat.

Attendees are encouraged to send questions or requests to speak in advance of the meeting to Cortney Alvord via email.

________________________________________________________________________________

Microsoft Teams meeting
Join on your computer, mobile app or room device
Join the meeting

Meeting ID: 218 762 770 115
Passcode: 7Hdkxm
Download Teams | Join on the web

Or call in (audio only)
+1 267-332-8737,,881854265# tel:+12673328737,,881854265#
United States, Philadelphia
Phone Conference ID: 881 854 265#

February continues the series on Participant Directed Services. Creating an Everyday Life using Waiver Services comes with some exciting opportunities and challenges. Many individuals use Participant Directed Services to pursue their vision and create the life they want. Please join the PA Family Network (PAFN) as they explore more about Participant Direction and offer resources and information. These workshops are created by family members and self-advocates FOR family members and self-advocates.

Register here for upcoming events.

Support Groups

LifeCourse Workshops

Waiver Workshops

  • Waiver Advanced, Part 1: Monday, February 5, 2024
  • Waiver Advanced, Part 2: Monday, February 12, 2024
  • Waiver Basics, Part 1: Thursday, February 22, 2024

Community Engagement Workshops:
There will be an afternoon and evening session each day.

Join us for our Participation Direction Summits this spring!

Visit the PA Family Network website for more information about our summit sessions, lunch, and dinner!

The 2024 RCPA Conference Embracing Challenges, Empowering Success will be held September 24 – 27 at the Hershey Lodge for a statewide audience. The Conference Committee is seeking workshop proposals in every area for possible inclusion, particularly those that assist providers in developing and maintaining high-quality, stable, and effective treatments, services, and agencies in an industry where change is constant. The committee looks for presentations that:

  • Highlight new policy, research, and treatment initiatives, such as the use of artificial intelligence, telehealth innovations, and employing people with disabilities;
  • Provide specific skills and information related to individual and organizational leadership development and enhancement;
  • Discuss advanced ethics practices and suicide prevention;
  • Address system changes that affect business practices, including integrated care strategies, value-based purchasing, performance-based contracting, acquisitions and mergers, and alternative payment models;
  • Provide guidance on building a culture of a committed workforce, including recruitment and employee development as well as effective remote workforce strategies;
  • Offer concrete skills and tools to operate more efficient, effective businesses; and
  • Inspire ideas for organizations to be leaders in their field.

The committee welcomes any proposal that addresses these and other topics essential to rehabilitation, mental health, substance use disorder, children’s health, aging, physical disabilities, and intellectual/developmental disabilities & autism.

Members are encouraged to consider submitting, and we highly encourage you to forward this opportunity to those who are exceptionally good speakers and have state-of-the-art information to share.

The Call for Proposals (featuring a complete listing of focus tracks) and accompanying Guidelines for Developing Educational Objectives detail requirements for submissions. The deadline for submissions is Monday, March 11, 2024, at 5:00 pm. Proposals must be submitted electronically on the form provided; confirmation of receipt will be sent. Proposals submitted after the deadline will not be considered.

If the proposal is accepted, individuals must be prepared to present on any day of the conference. Workshops are 90 or 180 minutes in length. At the time of acceptance, presenters will be required to confirm the ability to submit workshop handouts electronically four weeks prior to the conference. Individuals unable to meet this expectation should not submit proposals for consideration.

Individuals are welcome to submit multiple proposals. Notification of inclusion for the conference will be made via email by Friday, May 17, 2024. Questions may be directed to Carol Ferenz, Conference Coordinator.